Major histocompatibility complex class I restricted cytotoxic T cells specific for natural melanoma peptides recognize unidentified shared melanoma antigen(s).
Data up to Jan 2025
Total Citations Per Year
Abstract
References (23)
Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.
1994 • 5,204 citations
Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells
1998 • 2,916 citations
Proliferating dendritic cell progenitors in human blood.
1994 • 1,922 citations
Role of Bone Marrow-Derived Cells in Presenting MHC Class I-Restricted Tumor Antigens
1994 • 1,185 citations
Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes.
1994 • 771 citations
A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E.
1992 • 694 citations
Tumor antigens recognized by T cells
1997 • 552 citations
A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma.
1995 • 416 citations
Inverse relationship of melanocyte differentiation antigen expression in melanoma tissues and CD8+ cytotoxic-T-cell responses: Evidence for immunoselection of antigen-loss variantsin vivo
1996 • 274 citations
Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes
1992 • 198 citations
In vivo priming of two distinct antitumor effector populations: the role of MHC class I expression.
1994 • 196 citations
Translation of a Retained Intron in Tyrosinase-related Protein (TRP) 2 mRNA Generates a New Cytotoxic T Lymphocyte (CTL)-defined and Shared Human Melanoma Antigen Not Expressed in Normal Cells of the Melanocytic Lineage
1998 • 141 citations
Human tumor antigens recognized by T-cells
1997 • 121 citations
Identification of New Melanoma Epitopes on Melanosomal Proteins Recognized by Tumor Infiltrating T Lymphocytes Restricted by HLA-A1, -A2, and -A3 Alleles
1998 • 114 citations
Cytotoxic T cells directed to tumor antigens not expressed on normal melanocytes dominate HLA-A2.1-restricted immune repertoire to melanoma.
1996 • 90 citations
HLA-Independent Heterogeneity of CD8+ T Cell Responses to MAGE-3, Melan-A/MART-1, gp100, Tyrosinase, MC1R, and TRP-2 in Vaccine-Treated Melanoma Patients
1998 • 86 citations
Natural variation of the expression of HLA and endogenous antigen modulates CTL recognition in anIn vitro melanoma model
1999 • 83 citations
High homogeneity of MAGE, BAGE, GAGE, Tyrosinase and Melan-A/MART-1 gene expression in clusters of multiple simultaneous metastases of human melanoma: Implications for protocol design of therapeutic antigen-specific vaccination strategies
1998 • 57 citations
Stringent Allele/Epitope Requirements for MART-1/Melan A Immunodominance: Implications for Peptide-Based Immunotherapy
1998 • 56 citations
Use of synthetic peptides to establish anti-human acetylcholine receptor CD4+ cell lines from myasthenia gravis patients.
1990 • 50 citations
Human Melanoma Cells Transfected with the B7-2 Co-Stimulatory Molecule Induce Tumor-Specific CD8+ Cytotoxic T Lymphocytes In Vitro
1998 • 29 citations
Particulate naturally processed peptides prime a cytotoxic response against human melanoma in vitro.
1996 • 17 citations
CD4+ Th0 cell clones, isolated from a metastatic lymph node of a melanoma patient, possess cytolytic function
1995 • 1 citations